Cardiac myosin binding protein C and MAP-kinase activating death domain-containing gene polymorphisms and diastolic

Cho-Kai Wu1, Yin-Tsen Huang, Jen-Kuang Lee

  • 1Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan.

Plos One
|April 25, 2012
PubMed

Insights

A specific gene variant, rs2290149 in the MYBPC3 gene, is linked to diastolic heart failure (DHF). This finding may help identify individuals at risk for DHF in the Chinese population.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Epidemiology

Background:

  • Myosin binding protein C (MYBPC3) is crucial for heart muscle function, particularly ventricular relaxation.
  • Diastolic heart failure (DHF) represents a significant clinical challenge, often linked to impaired cardiac relaxation.
  • Understanding the genetic underpinnings of DHF is essential for early diagnosis and risk stratification.

Purpose of the Study:

  • To investigate the association between genetic variations in the MYBPC3 gene and the risk of developing diastolic heart failure (DHF).
  • To identify specific single nucleotide polymorphisms (SNPs) and haplotypes within the MYBPC3 gene that are significantly correlated with DHF in a human population.

Main Methods:

  • A case-control study was conducted with 176 DHF patients and matched controls.
  • Twelve tagging SNPs across a 40 kb region of the MYBPC3 gene were genotyped.
  • Linkage disequilibrium (LD) analysis and haplotype construction were performed to assess genetic associations with DHF.

Main Results:

  • Single locus analysis identified SNP rs2290149 as significantly associated with DHF (p = 0.004).
  • This SNP demonstrated an odds ratio of 2.14 for the additive model and 2.06 for the dominant model, indicating increased DHF risk.
  • A specific haplotype (C-C-G-C) containing rs2290149 was also significantly associated with DHF (p = 0.029).

Conclusions:

  • A significant association was found between the MYBPC3 gene polymorphism rs2290149 and early diastolic heart failure (DHF).
  • This genetic marker may contribute to understanding DHF susceptibility in the Chinese population.
  • Further research is warranted to explore the functional implications of this genetic association.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...